Multi-parametric MRI/US fusion guided biopsy for the diagnosis of prostate cancer. ur experience

Глыбочко П. В., Аляев Ю. Г., Амосов А. В., Еникеев Д. В., Чинёнов Д. В., Крупинов Г. Е., Пузаков К. Б., Кошкарев А. В., Лернер Ю. В., Петровскии Н. В., Джалаев З. К., Чернов Я. Н.

Урология

Вып. 3, С. 98-104

Опубликовано: 2018

Тип ресурса: Статья

DOI:10.18565/urology.2018.3.98-104

Аннотация:

INTRODUCTION: Prostate cancer is one of the most common types of cancer in men. The gold standard for the detection of prostate cancer is ultrasound guided transrectal prostate biopsy. The detectability of cancer using this method is from 30 to 50[%]. As a result, many men undergo multiple repeat biopsies for suspected prostate cancer. The European Association of Urology does not give any recommendations on this matter. A revolutionary new method in the diagnosis of prostate cancer is a targeted prostate biopsy using a fusion of multiparametric magnetic resonance imaging (MRI) and ultrasound. MATERIALS AND METHODS: At the R.M. Fronstein Clinic of Urology, 55 patients with suspected prostate cancer from September 2017 to January 2018 underwent fusion prostate biopsy. Of them, 21 patients had negative primary biopsies. Two patients had verified prostate cancer. 32 patients did not undergo primary biopsies. RESULTS: The findings of the study suggest that using MRI-ultrasound fusion for guid

Ключевые слова:

diagnosis of prostate cancer; prostate cancer; standard and fusion-biopsy

cancer grading; diagnostic imaging; human; male; nuclear magnetic resonance imaging; pathology; procedures; prostate; prostate tumor; sensitivity and specificity; transrectal high intensity focused ultrasound; Humans; Magnetic Resonance Imaging; Male; Neoplasm Grading; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Ultrasound, High-Intensity Focused, Transrectal

Язык текста: Русский

ISSN: 1728-2985

Глыбочко П. В. Петр Витальевич 1964-

Аляев Ю. Г. Юрий Геннадьевич 1942-

Амосов А. В. Александр Валентинович 1953-

Еникеев Д. В. Дмитрий Викторович 1982-

Чинёнов Д. В. Денис Владимирович 1978-

Крупинов Г. Е. Герман Евгеньевич 1970-

Пузаков К. Б. Кирилл Борисович 1985-

Кошкарев А. В. Алексей Викторович 1991-

Лернер Ю. В. Юлия Владимировна 1981-

Петровскии Н. В.

Джалаев З. К. Зураб Курбанмагомедович 1991-

Чернов Я. Н. Ярослав Николаевич 1991-

Gly'bochko P. V. Petr Vitalyevich 1964-

Alyaev Yu. G. Yurij Gennadyevich 1942-

Amosov A. V. Aleksandr Valentinovich 1953-

Enikeev D. V. Dmitrij Viktorovich 1982-

Chinyonov D. V. Denis Vladimirovich 1978-

Krupinov G. E. German Evgenyevich 1970-

Puzakov K. B. Kirill Borisovich 1985-

Koshkarev A. V. Aleksej Viktorovich 1991-

Lerner Yu. V. Yuliya Vladimirovna 1981-

Petrovskii N. V.

Dzhalaev Z. K. Zurab Kurbanmagomedovich 1991-

Chernov Ya. N. Yaroslav Nikolaevich 1991-

Multi-parametric MRI/US fusion guided biopsy for the diagnosis of prostate cancer. ur experience

Текст визуальный непосредственный

Урология

Бионика Медиа

Вып. 3 С. 98-104

2018

Статья

diagnosis of prostate cancer prostate cancer standard and fusion-biopsy

cancer grading diagnostic imaging human male nuclear magnetic resonance imaging pathology procedures prostate prostate tumor sensitivity and specificity transrectal high intensity focused ultrasound Humans Magnetic Resonance Imaging Male Neoplasm Grading Prostate Prostatic Neoplasms Sensitivity and Specificity Ultrasound, High-Intensity Focused, Transrectal

INTRODUCTION: Prostate cancer is one of the most common types of cancer in men. The gold standard for the detection of prostate cancer is ultrasound guided transrectal prostate biopsy. The detectability of cancer using this method is from 30 to 50[%]. As a result, many men undergo multiple repeat biopsies for suspected prostate cancer. The European Association of Urology does not give any recommendations on this matter. A revolutionary new method in the diagnosis of prostate cancer is a targeted prostate biopsy using a fusion of multiparametric magnetic resonance imaging (MRI) and ultrasound. MATERIALS AND METHODS: At the R.M. Fronstein Clinic of Urology, 55 patients with suspected prostate cancer from September 2017 to January 2018 underwent fusion prostate biopsy. Of them, 21 patients had negative primary biopsies. Two patients had verified prostate cancer. 32 patients did not undergo primary biopsies. RESULTS: The findings of the study suggest that using MRI-ultrasound fusion for guid